Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma
(Q44653322)
scientific article published on November 1, 2003
scientific article published on November 1, 2003
Language: